Most downloaded
- Page Path
-
- HOME
- BROWSE ARTICLES
- Most downloaded
"Most downloaded" Articles are from the articles published in 2022 during the last six months.
- Editorial
- Nutrition
- Human milk oligosaccharides as immunonutrition key in early life
(4 times)
-
Jung Ok Shim
-
Clin Exp Pediatr. 2022;65(7):344-345. Published online May 3, 2022
-
|
|
· Human milk is a major source of immunonutrients for neonates and infants. Human milk oligosaccharides (HMOs) act as prebiotics and promote the growth of commensal bacteria.
· HMOs inhibit microorganism adhesion to the gut mucosa through interactions with the commensal microbiome and improve gut barrier function by increasing short-chain fatty acid mediated by bifidobacteria and immunomodulation.
· Several randomized controlled trials recently reported on HMOs. |
-
-
- Other
- Three-dimensional printing technolgy in orthopedic oncology
(4 times)
-
Yongsung Kim
-
Clin Exp Pediatr. 2022;65(10):496-497. Published online May 11, 2022
-
|
|
Orthopedic oncology is one of the most active fields in applying 3-dimensional printing technology from preoperative planning to intraoperative procedures such as accurate resection of tumors and reconstruction of huge bone defects. |
-
-
- Original Article
- Hematology
- Effect of cyclic pamidronate administration on osteoporosis in children with β-thalassemia major: a single-center study
(4 times)
-
Mahmoud A. El-Hawy, Nagwan Y. Saleh
-
Clin Exp Pediatr. 2022;65(8):405-409. Published online June 7, 2022
-
|
Question: What is the effect of cyclic pamidronate administration on osteoporosis in children with β-thalassemia major?
Finding: The dual-energy x-ray absorptiometry scan findings of children with β-thalassemia major and osteoporosis were improved after pamidronate administration.
Meaning: Cyclic pamidronate effectively treated osteoporosis in children with β-thalassemia major. |
-
-
- Editorial
- Neurobehavior
- Impact of coronavirus disease 2019 on children’s health
(4 times)
-
Joon Won Kang
-
Clin Exp Pediatr. 2022;65(10):498-499. Published online September 16, 2022
-
|
· Coronavirus disease 2019 (COVID-19) has had an enormous impact on mental health and other aspects of children’s health.
· The prevalence of anxiety, depression, and posttraumatic stress disorder in children and adolescents have increased in the COVID-19 era.
· Cooperation among parents, guardians, academic societies, and the government is needed to maintain the mental health of children and adolescents. |
-
-
- Letter to the Editor
- Neonatology (Perinatology)
- Telemedicine as progressive treatment approach for neonatal jaundice due to the coronavirus disease 2019 pandemic
(1 time)
-
Sukanya Sudhir Joshi, Bithiah Roy Benroy, Isabell Nelson Lawrence, Thanuja Jayasri Suresh
-
Clin Exp Pediatr. 2022;65(5):269-271. Published online February 7, 2022
-
|
|
Question: How can the management of neonatal jaundice (NJ) be enhanced through telemedicine?
Finding: Teleconsultations, drive-through testing, and the use of an application to assess neonatal jaundice at home are being successfully used, but they must be further researched before being implemented on a larger scale.
Meaning: Recent technology allows for the treatment of NJ at home with an application that helps reduce hospital burden. |
-
-
- Editorial
- Cardiology
- Early echocardiographic screening for subclinical myocardial dysfunction in children and adolescents with dyslipidemia: why and when?
(1 time)
-
Hyun Gyung Lee, Hwa Jin Cho
-
Clin Exp Pediatr. 2022;65(8):398-400. Published online March 7, 2022
-
|
Dyslipidemia contributes to early atherosclerosis, premature cardiovascular disease, and subclinical ventricular dysfunction in children. This paper highlights the need for echocardiographic evaluation for impaired diastolic function of both ventricles and narrowing of the aortic valve and sinus of Valsalva. Therefore, early echocardiographic screening of children with primary hyperlipidemia should be considered. |
-
-
- Allergy
- Clinical considerations and practical issues of allergic diseases in COVID-19 era
(1 time)
-
Sungsu Jung
-
Clin Exp Pediatr. 2022;65(12):587-588. Published online November 29, 2022
-
|
The risk of sudden acute respiratory syndrome coronavirus 2 infection and severe coronavirus disease 2019 (COVID-19) outcomes is not elevated in patients with the type 2 phenotype and well-controlled asthma. Inhaled corticosteroids, intranasal corticosteroids, and topical steroids can be safely used in COVID-19 patients. Biologics can be safely used by patients with allergic diseases without concern about antibody responses. |
-
-
